| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $14.0M | +0.0% |
| Cost of Revenue | $1.6M | +0.0% |
| Gross Profit | $12.4M | +0.0% |
| R&D Expense | $13.4M | -7.8% |
| SG&A Expense | $13.5M | +25.4% |
| Operating Income | -$26.9M | -108.6% |
| Interest Expense | $1.4M | +255.9% |
| Net Income | -$28.0M | -119.2% |
| EPS (Basic) | -$0.83 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.9M | +17.5% |
| Current Assets | $27.6M | +25.6% |
| Total Assets | $31.0M | -2.0% |
| Current Liabilities | $4.5M | -59.6% |
| Total Liabilities | $13.8M | +23.3% |
| Stockholders' Equity | $17.2M | -15.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.1M | -20.3% |
| Capital Expenditures | $540K | -55.9% |
| Investing Cash Flow | -$875K | +46.0% |
| Financing Cash Flow | $21.5M | +0.2% |
| Free Cash Flow | -$25.6M | -16.0% |
| -69.4% |
| EPS (Diluted) | -$0.83 | -69.4% |